Go Pro

Robert Burns Analyst Performance

Analyst at BTIG Research

Robert Burns is a stock analyst at BTIG Research focused in the medical sector, covering 50 publicly traded companies. Over the past year, Robert Burns has issued 138 stock ratings, including buy, hold, and sell recommendations. While full access to Robert Burns' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robert Burns' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
299 Last 6 Years
Buy Recommendations
91.61% 273 Buy Ratings
Companies Covered
50 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.3%1 ratings
Buy91.3%272 ratings
Hold8.1%24 ratings
Sell0.3%1 ratings

Out of 298 total stock ratings issued by Robert Burns at BTIG Research, the majority (91.3%) have been Buy recommendations, followed by 8.1% Hold, 0.3% Strong Buy, and 0.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
92.0% of companies on NASDAQ
46 companies
NYSE
4.0% of companies on NYSE
2 companies
OTCMKTS
2.0% of companies on OTCMKTS
1 company
NYSEAMERICAN
2.0% of companies on NYSEAMERICAN
1 company

Robert Burns, an analyst at BTIG Research, currently covers 50 companies listed on NASDAQ, NYSE, OTCMKTS and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
47 companies
94.0%
Manufacturing
2 companies
4.0%
Financial Services
1 company
2.0%

Robert Burns of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Financial Services companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
36 companies
72.0%
MED - DRUGS
5 companies
10.0%
PHARMACEUTICAL PREPARATIONS
4 companies
8.0%
BIOTECHNOLOGY
1 company
2.0%
Miscellaneous
1 company
2.0%
SURGICAL & MEDICAL INSTRUMENTS
1 company
2.0%
INVESTMENT OFFICES
1 company
2.0%
MED PRODUCTS
1 company
2.0%

Robert Burns' Ratings History at BTIG Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Telix Pharmaceuticals Limited stock logo
TLPPF
Telix Pharmaceuticals
7/28/2026Reiterated Rating$10.02Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
7/27/2026Boost Price Target$6.45$21.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
7/20/2026Lower Price Target$4.18$21.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
7/15/2026Reiterated Rating$4.39Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/10/2026Boost Price Target$24.69$34.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
7/9/2026Boost Price Target$50.80$64.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
7/7/2026Reiterated Rating$12.15$20.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
7/6/2026Reiterated Rating$3.98Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
7/6/2026Reiterated Rating$190.26$195.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
7/2/2026Reiterated Rating$53.96$56.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
6/18/2026Reiterated Rating$9.40Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
6/15/2026Boost Price Target$14.85$23.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
6/10/2026Reiterated Rating$15.64$32.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
6/9/2026Boost Price Target$31.12$66.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
6/8/2026Downgrade$1.03Neutral
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
6/8/2026Reiterated Rating$7.50$25.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
6/8/2026Reiterated Rating$1.98$7.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
6/8/2026Reiterated Rating$13.51$30.00Buy
Radiopharm Theranostics Limited - Sponsored ADR stock logo
RADX
Radiopharm Theranostics
6/4/2026Initiated Coverage$4.49$6.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
6/3/2026Reiterated Rating$24.11$46.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
6/2/2026Boost Price Target$19.81$35.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/1/2026Boost Price Target$163.40$195.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
6/1/2026Downgrade$1.90Neutral
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
5/28/2026Reiterated Rating$10.77$17.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
5/28/2026Reiterated Rating$5.28$7.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
5/26/2026Boost Price Target$13.53$28.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
5/22/2026Boost Price Target$8.90$20.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
5/11/2026Boost Price Target$1.94$11.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
5/7/2026Boost Price Target$48.70$56.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/6/2026Boost Price Target$36.97$55.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
5/6/2026Boost Price Target$9.41$13.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
5/5/2026Reiterated Rating$3.64$8.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
5/5/2026Reiterated Rating$4.45$17.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
5/4/2026Boost Price Target$1.53$7.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
4/29/2026Boost Price Target$13.03$25.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
4/29/2026Boost Price Target$2.70$11.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
4/28/2026Boost Price Target$12.85$30.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
4/27/2026Boost Price Target$4.70$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/27/2026Reiterated Rating$16.68$32.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/27/2026Reiterated Rating$105.46$130.00Buy
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/22/2026Reiterated Rating$148.90Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
4/22/2026Reiterated Rating$4.49$13.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
4/14/2026Boost Price Target$3.04$12.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
4/13/2026Reiterated Rating$10.54$20.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
4/13/2026Reiterated Rating$4.77Sell
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/10/2026Reiterated Rating$16.24$32.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
4/7/2026Reiterated Rating$1.95$9.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
4/7/2026Reiterated Rating$9.09$20.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
4/2/2026Reiterated Rating$7.47$25.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/31/2026Lower Price Target$85.25$130.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
3/31/2026Boost Price Target$16.54$33.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
3/31/2026Boost Price Target$19.04$42.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
3/27/2026Boost Price Target$8.72$15.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3/26/2026Boost Price Target$35.53$56.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
3/25/2026Lower Price Target$5.44$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
3/24/2026Reiterated Rating$14.69$32.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
3/23/2026Lower Price Target$6.92$27.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
3/23/2026Boost Price Target$9.91$19.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
3/23/2026Boost Price Target$3.88$8.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/23/2026Boost Price Target$4.45$13.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
3/16/2026Lower Price Target$3.78$27.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
3/16/2026Reiterated Rating$4.22$13.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
3/13/2026Boost Price Target$10.90$17.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
3/13/2026Reiterated Rating$11.76$25.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3/13/2026Reiterated Rating$4.05$7.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
3/9/2026Initiated Coverage$18.81$30.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/6/2026Boost Price Target$25.25$44.00Buy
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
3/6/2026Boost Price Target$9.89$29.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
3/6/2026Boost Price Target$16.80$27.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/6/2026Boost Price Target$24.80$46.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/24/2026Boost Price Target$12.46$25.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/18/2026Reiterated Rating$9.40$15.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/12/2026Boost Price Target$42.94$54.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/3/2026Reiterated Rating$42.81$52.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
2/3/2026Reiterated Rating$0.52$10.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
1/30/2026Boost Price Target$4.26$12.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2026Boost Price Target$17.87$32.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
1/28/2026Reiterated Rating$2.00$10.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
1/27/2026Initiated Coverage$4.09$13.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2026Boost Price Target$43.61$52.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
1/27/2026Initiated Coverage$4.00$13.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
1/21/2026Reiterated Rating$7.90$50.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
1/21/2026Reiterated Rating$7.73$20.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
1/14/2026Reiterated Rating$17.53Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/12/2026Lower Price Target$8.03$17.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
1/9/2026Reiterated Rating$0.75$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
1/8/2026Boost Price Target$10.71$27.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/8/2026Boost Price Target$44.79$52.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/6/2026Boost Price Target$34.26$52.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
12/22/2025Reiterated Rating$7.80$20.00Buy
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
12/11/2025Reiterated Rating$96.00$140.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
12/11/2025Boost Price Target$7.90$18.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
12/10/2025Boost Price Target$19.55$31.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
12/1/2025Reiterated Rating$8.05$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
11/20/2025Boost Price Target$9.10$26.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
11/18/2025Boost Price Target$23.90$32.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/14/2025Boost Price Target$13.08$23.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
11/13/2025Boost Price Target$35.26$50.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/10/2025Boost Price Target$103.14$140.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
11/7/2025Boost Price Target$10.83$144.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/6/2025Boost Price Target$59.34$73.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
11/5/2025Boost Price Target$2.17$9.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$39.06$49.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
11/4/2025Reiterated Rating$15.50$21.00Buy
MacroGenics, Inc. stock logo
MGNX
MacroGenics
11/3/2025Reiterated Rating$1.66$2.00Neutral
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
10/31/2025Upgrade$1.29$5.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
10/27/2025Reiterated Rating$17.87Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/27/2025Lower Price Target$11.98$28.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
10/27/2025Upgrade$8.80$12.00Buy
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
10/27/2025Lower Price Target$1.90$3.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10/20/2025Set Price Target$5.74$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/20/2025Reiterated Rating$9.84$33.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10/20/2025Initiated Coverage$5.86$7.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
10/16/2025Lower Price Target$4.24$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/14/2025Lower Price Target$9.72$33.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
10/14/2025Set Price Target$18.11$26.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
10/13/2025Upgrade$5.50$15.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
10/3/2025Reiterated Rating$3.49$10.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
9/23/2025Reiterated Rating$1.01$5.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
9/19/2025Reiterated Rating$3.16$10.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
9/19/2025Reiterated Rating$3.29$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
9/12/2025Reiterated Rating$6.62$24.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
9/12/2025Boost Price Target$2.22$8.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
9/10/2025Lower Price Target$9.66$20.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
9/8/2025Reiterated Rating$112.46$136.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
9/8/2025Reiterated Rating$6.33Neutral
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
8/26/2025Lower Price Target$3.51$14.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
8/26/2025Reiterated Rating$2.75$34.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
8/22/2025Lower Price Target$11.63$40.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
8/21/2025Initiated Coverage$7.47$24.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/14/2025Lower Price Target$9.83$19.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
8/14/2025Lower Price Target$111.87$136.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
8/12/2025Reiterated Rating$17.42$42.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
8/12/2025Lower Price Target$37.41$46.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
8/11/2025Lower Price Target$2.40$10.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
8/6/2025Reiterated Rating$8.52$8.60Neutral
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/6/2025Lower Price Target$11.36$21.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
8/6/2025Lower Price Target$2.57$10.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/23/2025Downgrade$2.81Neutral
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
7/23/2025Upgrade$12.03$64.00Strong-Buy
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
7/22/2025Reiterated Rating$21.55$40.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
7/17/2025Boost Price Target$9.05$13.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/16/2025Downgrade$4.24Neutral
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/14/2025Lower Price Target$12.42$34.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/11/2025Initiated Coverage$5.00$27.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
7/8/2025Boost Price Target$9.33$22.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
7/3/2025Initiated Coverage$16.50$23.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
7/3/2025Reiterated Rating$12.89$13.00Neutral
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/3/2025Reiterated Rating$9.55$22.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
7/2/2025Boost Price Target$19.65$48.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/30/2025Boost Price Target$43.67$53.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/25/2025Reiterated Rating$105.09$138.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/16/2025Lower Price Target$106.57$138.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/12/2025Reiterated Rating$41.43$47.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/5/2025Boost Price Target$111.21$145.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
6/4/2025Reiterated Rating$2.11$7.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/22/2025Reiterated Rating$99.09$134.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/20/2025Lower Price Target$5.03$12.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
5/19/2025Lower Price Target$4.10$11.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
5/15/2025Boost Price Target$19.89$40.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/14/2025Reiterated Rating$40.01$72.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/14/2025Reiterated Rating$93.89$134.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
5/14/2025Boost Price Target$18.76$40.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
5/9/2025Boost Price Target$2.63$18.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
5/5/2025Reiterated Rating$5.67$21.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
5/5/2025Reiterated Rating$0.89$5.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
4/28/2025Reiterated Rating$0.77$3.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
4/14/2025Reiterated Rating$1.41$13.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
4/8/2025Reiterated Rating$0.65$5.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
4/2/2025Reiterated Rating$4.95$10.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/2/2025Reiterated Rating$10.47$36.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/1/2025Lower Price Target$91.06$145.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
3/31/2025Reiterated Rating$1.49$8.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
3/27/2025Reiterated Rating$37.01$40.00Buy
MacroGenics, Inc. stock logo
MGNX
MacroGenics
3/25/2025Lower Price Target$1.96$2.00Neutral
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3/21/2025Boost Price Target$20.92$39.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
3/21/2025Lower Price Target$4.92$12.00Buy
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
3/20/2025Reiterated Rating$1.28$5.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
3/19/2025Lower Price Target$1.69$8.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
3/19/2025Reiterated Rating$0.95$9.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
3/18/2025Boost Price Target$1.71$12.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/13/2025Initiated Coverage$2.66$10.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/10/2025Lower Price Target$2.03$10.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/10/2025Boost Price Target$11.09$13.00Neutral
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
3/7/2025Lower Price Target$1.19$5.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
3/7/2025Reiterated Rating$3.48$16.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/7/2025Reiterated Rating$21.81$39.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
3/3/2025Initiated Coverage$2.41$13.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
3/3/2025Boost Price Target$40.74$73.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
2/28/2025Boost Price Target$4.06$17.00Buy
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/21/2025Reiterated Rating$7.63$21.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/13/2025Reiterated Rating$32.80$40.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
2/13/2025Boost Price Target$13.79$22.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/11/2025Reiterated Rating$11.23$21.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
2/10/2025Reiterated Rating$2.01$7.00Buy
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
1/30/2025Downgrade$13.19Neutral
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2025Boost Price Target$19.56$36.00Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
1/28/2025Reiterated Rating$7.37Neutral
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2025Reiterated Rating$32.38$40.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/23/2025Boost Price Target$2.65$11.00Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
1/22/2025Reiterated Rating$6.05Neutral
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
1/22/2025Boost Price Target$25.31$39.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
1/22/2025Boost Price Target$11.85$21.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/14/2025Lower Price Target$7.57$14.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
1/14/2025Reiterated Rating$4.78$16.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
1/13/2025Reiterated Rating$6.89$22.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
1/13/2025Reiterated Rating$8.29$21.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/10/2025Boost Price Target$34.50$40.00Buy